News: FDA Issues J&J Warning Over Faulty Stent Failures

Johnson & Johnson (JNJ), the world’s largest health-products company, failed to ensure that heart stents made at a plant in Puerto Rico worked properly, U.S. regulators said.
March 9, 2011
Sign up for our eNewsletters
Get the latest news and updates

Related

Fujifilm Biotechnologies to leverage downstream purification system at UK site
‘Cobots’ drive pharma’s shift toward scalable cell therapies
Arch Resources Saves with OnTrak System & Condition-Based Lubrication
Sponsored
Early Intervention with OnTrak Wireless for High-Heat Environments
Sponsored